Incidence of Anaphylaxis During Winter Events Highlights Importance of Adding a Preparedness Checklist to Holiday Planning

Incidence of Anaphylaxis During Winter Events Highlights Importance of Adding
                 a Preparedness Checklist to Holiday Planning

Mylan Specialty Offers Tips for Parents of Children with Life-Threatening
Allergies to Help Prepare for Seasonal Celebrations

PR Newswire

BASKING RIDGE, N.J., Dec. 18, 2012

BASKING RIDGE, N.J., Dec. 18, 2012 /PRNewswire/ -- Findings from an online
survey released today by Mylan Specialty L.P., the fully-integrated specialty
pharmaceutical business of Mylan Inc. (Nasdaq: MYL), reveal that, of those
surveyed, more than half (55%) of children with life-threatening allergies
have experienced anaphylaxis (a life-threatening allergic reaction) during a
winter holiday event, a statistic that rises to 70% among families in urban
areas. This holiday season, parents can give their children and those around
them a gift they can put to good use – a lesson in preparedness to help avoid
allergic triggers.

The survey, conducted by Harris Interactive and commissioned by Mylan
Specialty, included more than 300 U.S. parents of children with
life-threatening allergies and found that nearly 90% of their children have
holiday events planned with friends and family or at school. When asked about
habits surrounding how they help prevent or prepare for anaphylaxis during
these activities, nearly all parents are taking some type of proactive
measure. However, in their self-reporting, less than 60% of parents take some
of the commonly recommended measures: talking to their children about avoiding
allergens by reviewing food labels (57%); ensuring those they are celebrating
with are aware of their allergies (53%) and having access to epinephrine
auto-injectors at all times (56%).

Anaphylaxis is a life-threatening allergic reaction that is rapid in onset and
may cause death either through swelling that shuts off airways or through a
significant drop in blood pressure. Avoidance of allergic triggers is the
critical first step to help prevent anaphylaxis; however, accidental exposure
may still happen. To help parents be better prepared during the holidays, and
throughout the year, parents are urged to have an anaphylaxis action plan and
review it with their child. An anaphylaxis action plan includes avoiding known
allergens, recognizing symptoms, having access to two epinephrine
auto-injectors and seeking immediate emergency medical care.

"While the incidence of anaphylaxis during holiday events is disturbing,
perhaps more alarming is the low incidence of preparedness. The fact is that
for people at risk for anaphylaxis it can happen anywhere and at any time,"
said Todd A. Mahr, M.D., chair of the Section of Allergy and Immunology of the
American Academy of Pediatrics."As a physician and a parent of a child with
life-threatening allergies, I am encouraging others to revisit their
anaphylaxis action plan and to ensure access to appropriate treatment in the
event anaphylaxis occurs – not being prepared is just not an option."

According to food allergy guidelines released in December 2010 by the National
Institute of Allergy and Infectious Diseases (NIAID), a division of the
National Institutes of Health (NIH), epinephrine is the only first-line
treatment in all cases of anaphylaxis (including from food allergies) and
should be available at all times, in the form of two doses, to people at risk
for anaphylaxis. According to the guidelines, if experiencing anaphylaxis, a
person should use an epinephrine auto-injector and seek immediate emergency
medical attention.

EpiPen^® (epinephrine) Auto-Injector has been the number one prescribed
epinephrine auto-injector for more than 20 years and constitutes more than 99%
of the epinephrine auto-injector market. Carrying an epinephrine auto-injector
does not prevent patients from having an anaphylactic reaction; hence,
patients must avoid their allergens at all times.

"Food is very much a part of our nation's holiday celebrations, and that means
families managing potentially life-threatening allergies need to be extra
vigilant at this time of year," said Heather Bresch, CEO of Mylan. "To support
parents we are encouraging them to have a checklist to help avoid allergens
and to be prepared if anaphylaxis occurs."

FARE – formerly the Food Allergy & Anaphylaxis Network – has compiled the
following tips that could help alleviate some of the worries that go along
with the holiday season:

  oRSVP – ASAP! Be a great guest by contacting your host as soon as your
    invitation arrives. Start by communicating gently and by educating others;
    remember, your host is hoping to plan the "perfect" holiday party or meal.
  oThe rules. Go over "the rules" for parties with your kids in advance so
    that the most important safety rules, such as not eating a food unless he
    or she knows the ingredients, will be fresh in their minds when they
    arrive.
  oMake it and they will eat. Offer to bring safe food so that you know there
    will be something there that your child can eat and your host doesn't have
    to worry about separate food preparations. Share dishes that would be
    allergen-free.
  oShip ahead. If you're flying to visit friends or family, you may want to
    make some simple allergy-free foods that travel well and ship them to your
    host ahead of time.
  oStart the trend. Include an ingredient listing card with your food
    contribution to the party. Also, add an ingredient card to all food gifts
    you send out from your kitchen. This is a great opportunity to raise
    awareness at a party and with friends.
  oTag-team parenting. If your whole family is invited to a party, plan ahead
    with your spouse to divide the task of supervising your young child. With
    designated "on duty" times, your child will be supervised, and each parent
    will have time to socialize. This keeps little hands away from allergens
    that may be out (such as a bowl of chocolates or nuts).
  oCarry medications. Per the NIAID food allergy guidelines, always have
    immediate access to two doses of epinephrine just in case unrecognized
    food allergens are hiding in holiday treats.

For more information about managing food allergies, visit www.foodallergy.org.

About Anaphylaxis

Anaphylaxis is a life-threatening allergic reaction that has many possible
triggers, occurs quickly, without warning, and must be treated immediately
with epinephrine. Symptoms may include hives or redness of the skin, tightness
in the throat, nausea, dizziness, breathing problems, a decrease in blood
pressure and/or fainting. Anaphylaxis can be caused by triggers such as food,
stinging and biting insects, medicines, latex or even exercise. Epinephrine is
the only first-line treatment for anaphylaxis. According to the food allergy
guidelines developed by the National Institute of Allergy and Infectious
Diseases, if experiencing anaphylaxis, a person should use an epinephrine
auto-injector and seek immediate emergency medical attention. Epinephrine is a
naturally-occurring hormone, also known as adrenaline, and it should be
available at all times to patients at risk. Delays in epinephrine
administration have been associated with negative health consequences, even
possibly death.

Survey Methodology

The survey was conducted online, from August 24 to September 3, 2012 in the
United States by Harris Interactive, on behalf of Mylan Specialty. Final
results are among 302 U.S. adults, age 18+, who self-identified as caregivers
of at least one child with a life-threatening allergy to food and/or latex.
Data were weighted to be representative of U.S. adults who have children in
their household, according to U.S. Census Bureau statistics. This included
weighting by age, gender, income, region, educational status and propensity to
be online.

All sample surveys and polls, whether or not they use probability sampling,
are subject to multiple sources of error which are most often not possible to
quantify or estimate, including sampling error, coverage error, error
associated with nonresponse, error associated with question wording and
response options, and post-survey weighting and adjustments.

About EpiPen^® Auto-Injector

EpiPen^® and EpiPen Jr^® (epinephrine) Auto-Injectors are used for the
emergency treatment of life-threatening allergic reactions. Each EpiPen
2-Pak^® and EpiPen Jr 2-Pak^® contains two single auto-injectors,
instructions for use and a training device, with no drug product or needle, to
help patients become familiar with the administration technique. EpiPen
Auto-Injector should be administered immediately at the first sign of an
anaphylactic reaction. EpiPen Auto-Injector is not a substitute for emergency
medical treatment. [ ]Patients should seek emergency medical attention
immediately following administration. For more information about EpiPen
Auto-Injector, please visit www.epipen.com.

Indications

EpiPen^® (epinephrine) 0.3 mg and EpiPen Jr^® (epinephrine) 0.15 mg
Auto-Injectors are for the emergency treatment of life-threatening allergic
reactions (anaphylaxis) caused by allergens, exercise, or unknown triggers;
and for people who are at increased risk for these reactions.EpiPen and EpiPen
Jr are intended for immediate self administration as emergency supportive
therapy only. Seek immediate emergency medical treatment after use.

Important Safety Information

EpiPen Auto-Injectors contain a single dose of epinephrine, which you inject
into your outer thigh. DO NOT INJECT INTO YOUR VEIN, BUTTOCK, FINGERS, TOES,
HANDS OR FEET. In case of accidental injection, please seek immediate medical
treatment. Epinephrine should be used with caution if you have heart disease
or are taking certain medicines that can cause heart-related (cardiac)
symptoms.

Tell your doctor if you have certain medical conditions such as asthma,
depression, thyroid disease, Parkinson's disease, diabetes, high blood
pressure and heart disease, have any other medical conditions, are pregnant or
plan to become pregnant, or are breastfeeding or plan to breastfeed. Be sure
to also tell your doctor all the medicines you take, especially medicines for
asthma. If you have certain medical conditions, or take certain medicines,
your condition may get worse or you may have longer lasting side effects when
you take the EpiPen or EpiPen Jr Auto Injector.

The most common side effects may include increase in heart rate, stronger or
irregular heartbeat, sweating, nausea and vomiting, difficulty breathing,
paleness, dizziness, weakness or shakiness, headache, apprehension,
nervousness or anxiety. These side effects usually go away quickly, especially
if you rest.

Talk to your healthcare professional to see if EpiPen or EpiPen Jr
Auto-Injector is right for you.

Please click here or visit www.EpiPen.com to view the EpiPen Auto-Injector
prescribing information.

Please click here or visit www.EpiPen.com for the EpiPen Auto-Injector patient
insert.

You are encouraged to report negative side effects of prescription drugs to
the FDA.

Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

About Mylan Specialty

Mylan Specialty, a subsidiary of Mylan Inc. (Nasdaq: MYL), is a specialty
pharmaceutical company focused on the development, manufacturing and marketing
of prescription drug products for the treatment of respiratory diseases,
life-threatening allergic reactions and psychiatric disorders. For more
information, please visit www.mylanspecialty.com.

About Mylan

Mylan is a global pharmaceutical company committed to setting new standards in
health care. Working together around the world to provide seven billion people
access to high quality medicine, we innovate to satisfy unmet needs; make
reliability and service a habit, do what's right, not what's easy and impact
the future through passionate global leadership. We offer a growing portfolio
of more than 1,100 generic pharmaceuticals and several brand medications. In
addition, we offer a wide range of antiretroviral therapies, upon which
approximately one-third of HIV/AIDS patients in developing countries depend.
We also operate one of the largest active pharmaceutical ingredient
manufacturers and currently market products in approximately 150 countries and
territories. Our workforce of more than 18,000 people is dedicated to
improving the customer experience and increasing pharmaceutical access to
consumers around the world. But don't take our word for it. See for yourself.
See inside. Mylan.com.

EpiPen^®, EpiPen Jr^®, EpiPen 2-Pak^®, and EpiPen Jr 2-Pak^® are registered
trademarks of Mylan Inc. licensed exclusively to its wholly-owned subsidiary,
Mylan Specialty L.P.

© 2012 Mylan Specialty L.P. All rights reserved.

About Harris Interactive

Harris Interactive is one of the world's leading market research firms,
leveraging research, technology, and business acumen to transform relevant
insight into actionable foresight. Known widely for the Harris Poll® and for
pioneering innovative research methodologies, Harris offers proprietary
solutions in the areas of market and customer insight, corporate brand and
reputation strategy, and marketing, advertising, public relations and
communications research. Harris possesses expertise in a wide range of
industries including health care, technology, public affairs, energy,
telecommunications, financial services, insurance, media, retail, restaurant,
and consumer package goods. Additionally, Harris has a portfolio of
multi-client offerings that complement our custom solutions while maximizing
our client's research investment. Serving clients in more than 196 countries
and territories through our North American and European offices, Harris
specializes in delivering research solutions that help us - and our
clients—stay ahead of what's next. For more information, please visit
www.harrisinteractive.com.

EPI12-8113/EPI517401-01





SOURCE Mylan Inc.

Website: http://www.mylan.com
Contact: Nina Devlin (Media), +1-724-514-1968, or Kris King (Investors),
+1-724-514-1813
 
Press spacebar to pause and continue. Press esc to stop.